CIK 0000882796
- Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 621413174
- Phone
- +1 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-15 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −7,250 | $7.92 | $57K | 130,176 |
| 2019-05-15 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −4,750 | 65,750 | ||
| 2019-05-14 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +4,500 | $1.42 | $6K | 137,176 |
| 2019-05-14 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −4,500 | $7.62 | $34K | 132,676 |
| 2019-05-14 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −4,500 | 70,500 | ||
| 2019-05-13 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +9,750 | $5.51 | $54K | 142,426 |
| 2019-05-13 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −9,750 | $7.76 | $76K | 132,676 |
| 2019-05-13 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −9,750 | 131,250 | ||
| 2019-05-09 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +9,750 | $5.51 | $54K | 142,426 |
| 2019-05-09 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −9,750 | $7.63 | $74K | 132,676 |
| 2019-05-09 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −9,750 | 141,000 | ||
| 2019-05-06 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +9,000 | $5.51 | $50K | 141,676 |
| 2019-05-06 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −9,000 | $7.75 | $70K | 132,676 |
| 2019-05-06 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −9,000 | 150,750 | ||
| 2019-05-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +7,750 | $5.51 | $43K | 140,426 |
| 2019-05-02 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −7,750 | $7.30 | $57K | 132,676 |
| 2019-05-02 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −7,750 | 159,750 | ||
| 2019-04-04 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise | +7,500 | $5.51 | $41K | 140,176 |
| 2019-04-04 | STAAB THOMAS R II Senior Vice President and CFO | Sale | −7,500 | $8.81 | $66K | 132,676 |
| 2019-04-04 | STAAB THOMAS R II Senior Vice President and CFO | Option exercise · Emp. Stock Option (Right to Buy) | −7,500 | 167,500 |
Page 29 of 38 · 750 trades